Skip to main content

Day: July 8, 2022

Nutralife Biosciences Executes a Joint Venture Agreement With Emergent Health Corporation for the Co-Production, Co-Marketing, and Distribution of Emergent’s Line of Regenerative, and Other Health-Related Nutraceutical, Skincare and Pet Pro

COCONUT CREEK, FL, July 08, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – NutraLife Biosciences Inc. (OTC: NLBS), a manufacturer and distributor of private label and branded nutraceutical and skincare products, today announced it has executed a joint venture agreement with Emergent Health Corp. (“Emergent”) (OTC: EMGE) for the co-production, co-marketing, and distribution of Emergent’s line of regenerative, and other health-related nutraceutical products. Nutralife is a developer, manufacturer, and distributor of various nutraceutical and skincare products with more than 50 different products and formulations. NutraLife products are made with the finest, most effective ingredients, some of which include CBD. These products by design support and cater to a multitude of health and wellness applications to help and improve one’s quality...

Continue reading

Acer Therapeutics and Relief Therapeutics Announce That the China National Intellectual Property Administration (CNIPA) Issued Utility Model Patent 11,202,767 Covering ACER-001 Dosage Form

Key patent strengthens proprietary position in China until August 2031 NEWTON, Mass. and GENEVA, July 08, 2022 (GLOBE NEWSWIRE) — Acer Therapeutics Inc. (Nasdaq: ACER) (Acer) and its collaboration partner, RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) (Relief), today announced that the China National Intellectual Property Administration (CNIPA) issued Electronic Patent Certificate ZL202122004991.9 on May 24, 2022, for Utility Model directed to ACER-001 (sodium phenylbutyrate). Specifically, the newly issued patent covers dosage form claims related to ACER-001’s polymer coated formulation for oral administration as a potential treatment for urea cycle disorders (UCDs) and Maple Syrup Urine Disease (MSUD). The newly issued patent has an expiration date of August 24, 2031. “The receipt of this patent from the CNIPA...

Continue reading

Runway Growth Finance Corp. Announces Date for Second Quarter 2022 Financial Results and Conference Call

WOODSIDE, Calif., July 08, 2022 (GLOBE NEWSWIRE) — Runway Growth Finance Corp. (Nasdaq: RWAY) (“Runway Growth”), a leading provider of flexible capital solutions to late- and growth-stage companies seeking an alternative to raising equity, today announced that it will release its second quarter 2022 financial results after market close on Thursday, August 4, 2022. Runway Growth will discuss its financial results on a conference call that day at 3:00 p.m. PT (6:00 p.m. ET). To participate in the conference call or webcast, participants should register online at the Runway Growth Investor Relations website. Participants are requested to register a day in advance or at a minimum 15 minutes before the start of the call. The earnings call can also be accessed through the following links:Conference Call WebcastA replay of the webcast...

Continue reading

SFLMaven Begins to Form an Independent Board of Directors

Several New Directors are Named as the Company Seeks to Qualify for Uplisting with This Important Milestone FORT LAUDERDALE, FL, July 08, 2022 (GLOBE NEWSWIRE) — SFLMaven Corp. (OTC Pink: SFLM), (“SFLMaven” or the “Company”) (www.sflmaven.com), a leading provider of high-end luxury goods, recently announced its plans to begin the process of preparing the company for uplisting and acquisitions. See the previous PR Here: SFLM Press Release 2022/06/22. Now, the company focuses on forming and finalizing an independent board of directors. By forming an independent board of directors, the company will tackle a significant milestone towards qualifying for an uplisting to a higher OTC Market Tier such as OTC: QB or, for the potential uplist to NASDAQ with an S1 IPO type funding round. CEO Joseph Ladin said: “We...

Continue reading

iRhythm® Technologies Comments on the Proposed Medicare Physician Fee Schedule Released by the Centers for Medicare and Medicaid Services for Calendar Year 2023

SAN FRANCISCO, July 08, 2022 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today provided comment on the recently released Centers for Medicare and Medicaid Services (“CMS”) Medicare Physician Fee Schedule Proposed Rule for Calendar Year 2023 (the “Proposed Rule”). The Proposed Rule was released on July 7, 2022 and proposes to update the payment rates and other provisions for services furnished on or after January 1, 2023 and reimbursed under the Medicare Physician Fee Schedule (“MPFS”). The Proposed Rule is followed by a public comment period which will culminate with CMS’ release of a Final Rule, which is expected to be announced by early November for implementation on January 1, 2023. The policies announced in the Proposed...

Continue reading

Safe-T Group Launches its Consumer Privacy Solution for Microsoft Windows

The New Desktop Privacy Solution Prevents a User’s Personal Data, Online Activity and History from Being Accessed or Monitored by Internet Service Providers, Advertisers and Third Parties HERZLIYA, Israel, July 08, 2022 (GLOBE NEWSWIRE) — Safe-T Group Ltd. (Nasdaq: SFET) (TASE: SFET) (“Safe-T” or the “Company”), a global provider of cyber-security and privacy solutions for consumers and enterprises, today announced its entrance into the home computer market with the release of its first consumer privacy solution designed for Windows personal computers (“PCs”). Building upon the success and best-of-breed technology of its iOS privacy solution currently helping protect thousands of mobile devices, Safe-T is expanding its offerings into the global Windows PC market. Today, with approximately 50% of worldwide data traffic originating...

Continue reading

SciSparc Announces Expanding its Clinical Operations to Include a U.S. Site Towards its Phase IIb Trial with its Proprietary SCI-110 for the Treatment of Tourette Syndrome

TEL AVIV, Israel, July 08, 2022 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, today announced it has started the process of preparing for an Investigational New Drug Application (“IND”) with the U.S. Food and Drug Administration (“FDA”) for its Phase IIb clinical trial for SCI-110 in patients suffering from Tourette Syndrome (“TS”). The work towards an IND submission is intended to open a U.S. clinical site that will take part in the phase IIb trial. “We are very excited about expanding our clinical sites to the U.S., especially after positive results obtained in a clinical trial led by Prof. Bloch M.D., M.S., an associate Professor...

Continue reading

Grayscale® Digital Large Cap Fund, Grayscale® DeFi Fund, and Grayscale® Smart Contract Platform Ex-Ethereum Fund Announce Rebalancing of Funds for Second Quarter 2022

NEW YORK, July 08, 2022 (GLOBE NEWSWIRE) — Grayscale Investments®, the world’s largest digital currency asset manager, and manager of Grayscale® Digital Large Cap Fund (OTCQX: GDLC) (Digital Large Cap Fund), Grayscale® DeFi Fund (DeFi Fund), and Grayscale® Smart Contract Platform Ex-Ethereum Fund (GSCPxE Fund), today announced the updated Fund Component weightings for each product in connection with their respective second quarter 2022 reviews. In accordance with the CoinDesk Large Cap Select Index methodology, Grayscale has adjusted the Digital Large Cap Fund’s portfolio by selling certain amounts of the existing Fund Components in proportion to their respective weightings. As a result of the rebalancing, Bitcoin Cash, Chainlink, Litecoin, Polkadot and Uniswap have been removed from the Digital Large Cap Fund. No new tokens were...

Continue reading

Nano Dimension Acquires Admatec and Formatec, Creating Metal & Ceramic Additive Manufacturing Portfolio

An Unparalleled Opportunity to Expand its Multi Material 3D Printing with Best-in-Breed Printing Process and Service Bureau Waltham, Massachusetts, July 08, 2022 (GLOBE NEWSWIRE) — Nano Dimension Ltd. (Nasdaq: NNDM, “Nano Dimension” or the “Company”), a leading supplier of Additively Manufactured Electronics (“AME”) and multi-dimensional metal & ceramic Additive Manufacturing (“AM”) 3D printers, announced today that it has signed and closed a definitive agreement to acquire Formatec Holding B.V (“Admatec/Formatec”), which includes its two subsidiaries – Admatec Europe B.V. (“Admatec”) and Formatec Technical Ceramics B.V. (“Formatec”). Admatec/Formatec, based in the Netherlands, are comprised of two complementary businesses operating together, which were part of the U.S.-based Precision Surfacing Solutions. It is a...

Continue reading

AITX’s Subsidiary Robotic Assistance Devices Receives Multiple ROSA Order

Artificial Intelligence Technology Solutions, Inc. Illustration of 2 RAD ROSA 3.0 security robots in simulated autonomous response mode. RAD has received an order for 2 ROSA devices from one of its dealers.Detroit, Michigan, July 08, 2022 (GLOBE NEWSWIRE) — Artificial Intelligence Technology Solutions, Inc., (OTCPK:AITX), today announced that its wholly owned subsidiary Robotic Assistance Devices, Inc. (RAD) has received an order for 2 ROSA security robots from one of its dealer channel partners. The 2 ROSAs will be deployed at 2 separate convenience store chains. RAD’s ROSA has been well received by convenience stores and other small retail operators for its unequaled ability to detect and deter instances of trespassing and loitering without the need for manned guarding assistance. “It’s impressive to see our dealers continue...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.